Valuation: EDAP TMS S.A.

Market Cap 204M 178M 164M 152M 288M 19.43B 293M 1.96B 771M 9.57B 765M 748M 32.9B P/E 2026 *
-6.27x
P/E 2027 * -8.46x
Enterprise Value 204M 178M 164M 152M 288M 19.43B 293M 1.96B 771M 9.57B 765M 748M 32.9B EV / Sales 2026 *
3.13x
EV / Sales 2027 * 2.73x
Free-Float
32.89%
Yield 2026 *
-
Yield 2027 * -
1 day-0.82%
1 week+4.92%
Current month+4.92%
1 month+15.15%
3 months+64.70%
6 months+32.56%
Current year+65.20%
1 week 5.19
Extreme 5.19
5.64
1 month 4.65
Extreme 4.65
5.64
Current year 3.1
Extreme 3.1
5.64
1 year 1.21
Extreme 1.21
5.64
3 years 1.21
Extreme 1.21
9.45
5 years 1.21
Extreme 1.21
12.65
10 years 1.21
Extreme 1.21
12.65
Manager TitleAgeSince
Chief Executive Officer 64 2023-04-30
Director of Finance/CFO 55 2023-12-31
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 64 2023-04-30
Chairman 64 2024-08-31
Director/Board Member 62 2024-07-07
Date Insider Type Main position Quantity % Market Cap.
05-11Free

SVP, Marketing & Product Mgmt.

190,000 0.5145%
05-11Free

Chief Financial Officer

264,141 0.7153%
05-11Free

Chairman

114,285 0.3095%
Change 5-day change 1-year change 3-year change Capi.($)
-0.82%+4.92%+256.39%-38.66% 204M
+0.45%+0.69%+21.20%+0.21% 196B
-1.16%-4.51%-20.56%+17.03% 144B
+1.57%+0.57%-2.83%-16.40% 141B
-0.49%-0.82%-56.62%-14.66% 66.54B
+0.96%-2.29%+18.14%-0.96% 53.09B
+1.88%+1.00%-23.40%-31.19% 44.12B
+0.52%+2.75%+8.93%+11.91% 37.93B
-0.19%-0.75%+6.66%+39.97% 36.96B
0.00%-1.32%-13.88%-20.80% 29.43B
Average +0.56%-0.19%+19.40%-5.35% 74.91B
Weighted average by Cap. +0.80%-0.83%-3.76%-1.21%

Financials

2026 *2027 *
Net sales 65.18M 57.02M 52.59M 48.57M 92.16M 6.22B 93.72M 628M 247M 3.06B 245M 239M 10.53B 74.6M 65.26M 60.19M 55.59M 105M 7.12B 107M 719M 282M 3.51B 280M 274M 12.05B
Net income -32.13M -28.11M -25.92M -23.94M -45.43M -3.06B -46.2M -310M -122M -1.51B -121M -118M -5.19B -25.95M -22.7M -20.94M -19.34M -36.69M -2.47B -37.31M -250M -98.24M -1.22B -97.43M -95.31M -4.19B
Net Debt - -
Logo EDAP TMS S.A.
Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
Employees
289
Date Price Change Volume
26-07-10 US$5.435 -0.82% 46,561
26-07-09 US$5.480 +1.01% 44,466
26-07-08 US$5.425 +1.40% 22,767
26-07-07 US$5.350 +1.61% 38,222
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
5.435USD
Average target price
6.875USD
Spread / Average Target
+26.49%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. FOCL Stock